VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ)

$0.171 0.001 (0.5882%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 50

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ) News Sources

Scilex Holding Company (NASDAQ:SCLX) Is Expected To Breakeven In The Near Future

28-10-2025

yahoo.com

Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and Monetization of Real-World Asset (RWA) in Genomic, DNA Data, Diagnosis, Therapeutics Products, Genetic and Drug information from Datavault AI

04-11-2025

yahoo.com

Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, Therapeutics, Genetic, and Drug Information

04-11-2025

yahoo.com

Datavault AI Signs Binding Term Sheet for $120 Million Cash Contribution From Scilex

27-04-2026

yahoo.com

Wade Defendants Dispute Complaint and Statement by Scilex Holding Company

05-05-2026

yahoo.com

Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited

05-05-2026

yahoo.com

Wellgistics Health, Datavault AI Agree to Form DelivMeds AI

20-05-2026

yahoo.com

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

22-05-2026

yahoo.com

Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

04-06-2026

yahoo.com

Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

12-06-2026

yahoo.com

VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ) Sentiment Trend

0 25 50 75 100 55 55 56 52 12 56 51 55 55 53 28-10-2025 04-11-2025 27-04-2026 05-05-2026 20-05-2026 22-05-2026 04-06-2026 12-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ) FAQs

toggle

What is the current price of VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ)?

The current price of VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ) is $0.171.


toggle

VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ) absolute price change since previous trading day?

The absolute price change of VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ) since the previous trading day is $0.001.


toggle

VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ) percentage price change since previous trading day?

The percentage price change of VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ) since the previous trading day is 0.5882%.


toggle

What is the most recent average sentiment score for VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ)?

The most recent average sentiment score for VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ) is 50 out of 100.


toggle

What is the most recent average sentiment for VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ)?

The most recent sentiment for VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ) is .


SEC-8K** Filing Available For VICKERS VANTAGE CORP I -CW27 (SCLXW:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.